SIGLEC1 and COVID-19: SIGLEC1 (CD169) is an IFN-inducible gene that acts as an endocytic receptor mediating clathrin-dependent endocytosis and has been reported to be upregulated in circulating monocytes in COVID-19 patients57–60.